期刊文献+

综合干预前后我院剖宫产围手术期抗菌药物使用调查

Survey of Perioperative Antimicrobials of Cesarean Section in Our Hospital before and after the Comprehensive Intervention
下载PDF
导出
摘要 目的:调查综合干预前、中、后剖宫产围手术期抗菌药物使用情况,了解抗菌药物管理和干预效果,为促进合理用药提供依据。方法:分别抽取2011年10月—2012年3月(干预前)、2012年4月—2012年9月(干预中)、2012年10月—2013年3月(干预后)病历各80份,进行回顾性调查,对抗菌药物选择、联合用药、给药时机、疗程、费用、住院天数等进行统计分析。结果:干预后抗菌药物的品种选择主要是第一代或第二代头孢菌素,无联合用药,给药时机主要为钳夹脐带后,疗程大多控制在24 h内,抗菌药物使用费用明显降低。结论:通过我院各部门的综合干预,剖宫产围手术期应用抗菌药物已基本合理。 Objective: To investigate the use of perioperative antimicrobials in cesarean section before, during and after the comprehensive intervention, and to understand the effect of perioperative antimicrobial drug management and intervention measures, so as to provide a basis for further promoting the rational use of drugs.Methods:A total of 80 medical records before,during and after the comprehensive intervention,from the records of 2011.10-2012.03 (pre-intervention), 2012.04-2012.09 (intervention), 2012.10-2013.03 (after intervention) were respectively selected and surveyed retrospectively. The antimicrobials selection, combination therapy, timing of administration, period of treatment, cost, and days of hospitalization were comparatively analyzed.Results: After the intervention, the selection of antibiotics species is mainly ifrst or second-generation cephalosporins with no combination the rapy; timing of administration is mainly after cord clamping; the course has been basically controlled within 24h and antimicrobial drug costs were signiifcantly reduced.Conclusion: Perioperative use of antibiotics in cesarean section has become reasonable through hospital departments’ comprehensive intervention.
作者 何勇 周曙华
出处 《中国药事》 CAS 2015年第10期1107-1111,共5页 Chinese Pharmaceutical Affairs
关键词 剖宫产 围手术期 抗菌药物 综合干预 scesarean section perioperative period antibacterials comprehensive intervention
  • 相关文献

参考文献10

  • 1剖宫产手术的专家共识(2014)[J].中华妇产科杂志,2014,49(10):721-724. 被引量:278
  • 2卫生部,国家中医药管理局,总后卫生部.卫医发[2004] 285 抗菌药物临床应用指导原则[S].2004.
  • 3卫生部.卫办医发[2009]38号卫生部办公厅关于抗菌药物临床应用管理有关问题的通知[S].2009.
  • 4卫生部.卫办医政发[2009]111号卫生部办公厅关于印发8 个病种临床路径的通知[S].2009.
  • 5江建生,刘华强,孙福生,闫美兴.剖宫产手术围术期抗菌药物应用现状及干预[J].中国药房,2013,24(38):3629-3632. 被引量:8
  • 6Wilson JA,Clark JJ.Obesity:Impediment to Postsurgical Wound Healing[J].Adv Skin Wound Care,2004,17:426-35.
  • 7Tharpe N.Postpregnancy Genital Tract and Wound Infections[J].J Midwifery Womens Health,2008,53:236-46.
  • 8Wloch C,Wilson J,Lamagni T,et al.Risk Factors for Surgical Site Infection Following Caesarean Section in England:Results from Multicentre Cohort Study[J].BJOG,2012,119:1324-33.
  • 9Smaill FM,Gyte GML.Antibiotic Prophylaxis Versus no Prophylaxis for Preventing Infection after Cesarean Section[J].Cochrane Database Systemat Rev,2010,1:CD007482.
  • 10涂勤,刘莉,何雯,夏朝晖,陈艾,龙敏.剖宫产围手术期一剂抗生素应用效果观察[J].中国药房,2012,23(2):136-138. 被引量:12

二级参考文献48

  • 1欧定宏,黄婉群,龙启才.剖宫产产妇抗菌药物使用疗程的成本-效果分析[J].中国药物经济学,2008,0(5):13-18. 被引量:4
  • 2伍晓华,李彬彬.围手术期预防性用药,择机何时[J].中国医院用药评价与分析,2005,5(5):263-266. 被引量:50
  • 3无.围手术期预防应用抗菌药物指南[J].中华外科杂志,2006,44(23):1594-1596. 被引量:844
  • 4卫生部.卫生部医管司关于征求《普通外科Ⅰ类(清洁)切口手术围手术期预防用抗菌药物管理实施细则(征求意见稿)》《剖宫产手术围手术期预防用抗菌药物管理实施细则(征求意见稿)》意见的通知[EB/OL].http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohylfwjgs/s7656/200911/44702.htm,2009-11-25.2011-06-26.
  • 5马新秀.妇科围手术期抗菌药物合理应用的调研与干预[J].中国药房,2007,18(26):2020-2022. 被引量:7
  • 6利文诺.威廉姆斯产科学手册[M].21版.长沙:湖南科学技术出版社,2006:5.
  • 7Torloni MR,Betrán AP,Montilla P.Do Italian women prefer cesarean section?Results from a survey on mode of delivery preferences[J].BMC Pregnancy Childbirth,2013,26(13):78.
  • 8Althabe F,Belizan JF.Caesarean section:The paradox[J].The Lancet,2006,368(9 546):1 472.
  • 9Dinsmoor MJ,Gilbert S,Landon MB,et al.Perioperative antibiotic prophylaxis for non-Laboring cesarean delivery[J].Obstet Gynecol,2009,114(4):752.
  • 10Smaill F,Hofmeyr GJ.Antibiotic prophylaxis for cesarean section[J].Cochrane Database Syst Rev,2002(3):CD000933.

共引文献295

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部